You may feel pain on both sides of your head or just one. People who took Linzess for chronic idiopathic constipation (CIC) did not report headache.Ī headache can cause pain that’s throbbing, sharp, or dull. Headache was reported only in trials of people who took Linzess for irritable bowel syndrome with constipation (IBS-C). HeadacheĪlthough headache was not a common side effect in people who took Linzess in clinical trials, it may still occur. To find out how often side effects occurred in clinical trials, see the prescribing information for Linzess. Here’s some detail on certain side effects this drug may cause. * For more information about this side effect, see “Side effect details” below. Serious side effects* of Linzess can include: Call 911 or your local emergency number if your symptoms feel life threatening or if you think you’re having a medical emergency. Call your doctor right away if you have serious side effects. Serious side effects from Linzess aren’t common, but they can occur. † For more information about this side effect, see “Side effect details” below. To learn about other mild side effects, talk with your doctor or pharmacist, or see the Linzess prescribing information. * This is a partial list of mild side effects from Linzess. However, if they become more severe or don’t go away, talk with your doctor or pharmacist. Most of these side effects may go away within a few days to a couple of weeks. Mild side effects* of Linzess can include: If you would like to notify the FDA about a side effect you’ve had with Linzess, you can do so through MedWatch. Note: The Food and Drug Administration (FDA) tracks side effects of drugs it has approved.
Linzess 290 mcg how to#
They can give you tips on how to manage any side effects that may be concerning or bothersome. These lists do not include all possible side effects.įor more information about the possible side effects of Linzess, talk with your doctor or pharmacist. The following lists contain some of the key side effects that may occur while taking Linzess. They may vary depending on which condition the drug is used to treat. Since the launch of Linzess in December of 2012, nearly 1.5 million unique patients have filled nearly 7 million prescriptions, according to IMS Health data.īill Meury, chief commercial officer at Allergan, said, “This approval is testimony to the ongoing commitment of our organizations to continue to innovate with Linzess and to enhance patient care and refine the treatment of gastrointestinal disorders such as CIC.”Ĭhronic idiopathic constipation is a functional gastrointestinal disorder estimated to impact as many as 35 million adult Americans.Linzess can cause mild or serious side effects. “Linzess is the branded prescription market leader in the treatment of adult patients with IBS-C or CIC, and we believe the availability of a 72 mcg dose will enhance the product’s utility to physicians in treating patients across the broad CIC patient population, which encompasses up to 35 million adult Americans,” said Tom McCourt, chief commercial officer at Ironwood.
Linzess 290 mcg trial#
The approval of Linzess 72 mcg is based on results from a Phase III clinical trial of 1,223 adults with CIC. Linzess is now FDA-approved in three dosage strengths: 290 mcg for adult patients with irritable bowel syndrome with constipation (IBS-C), and 145 mcg and a new 72 mcg for the treatment of adults with CIC. The newly approved does is expected to available in the first quarter of this year. Food and Drug Administration approved Allergan and Ironwood Pharmaceutical’s Linzess (linaclotide) 72 mcg dose for the treatment of chronic idiopathic constipation in adult patients.
0 kommentar(er)
